Analyze my situation considering the DNA-Q and Manual Differential reports I uploaded today.

Myelodysplastic Syndrome (MDS)June 1, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

However, I don't see any documents attached to your message yet.

Please upload your reports by:

  • Clicking the paperclip icon in the chat
  • Dragging and dropping PDFs or images directly into this window
  • Taking a photo of printed reports and uploading that

Once you share them, I can help you understand:

  • What your test results mean in plain language
  • How they relate to your MDS and mixed donor chimerism status
  • What the values indicate about your immune recovery post-transplant
  • Questions to ask your care team based on your findings

Quick Context on Your Situation

I can see from your medical history that you're being monitored post-transplant with:

  • Mixed donor chimerism (detected [date removed]) — meaning you have a mix of your own cells and donor cells
  • IPSS-M moderate-low risk MDS — a relatively stable disease classification
  • CVID diagnosis (Common Variable Immunodeficiency) — which is why you're receiving IVIG infusions every 4 weeks
  • TP53 mutation negative — a good prognostic sign

Your DNA-Q and Manual Differential reports will give us important details about your immune cell counts and function, which is especially relevant given your CVID and post-transplant recovery.

Go ahead and upload those reports, and I'll walk you through what they show!


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: